GILDER GAGNON HOWE & CO LLC - TANDEM DIABETES CARE INC ownership

TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 307 filers reported holding TANDEM DIABETES CARE INC in Q2 2020. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.

Quarter-by-quarter ownership
GILDER GAGNON HOWE & CO LLC ownership history of TANDEM DIABETES CARE INC
ValueSharesWeighting
Q2 2023$66,503
-99.4%
2,710
-98.7%
0.00%
-99.4%
Q3 2022$10,335,000
-49.0%
215,980
-36.9%
0.18%
-50.1%
Q2 2022$20,271,000
-76.6%
342,473
-54.1%
0.36%
-55.0%
Q1 2022$86,790,000
-25.0%
746,324
-2.9%
0.80%
+21.7%
Q4 2021$115,736,000
+24.1%
768,906
-1.5%
0.66%
+36.4%
Q3 2021$93,236,000
+21.1%
781,006
-1.2%
0.48%
+27.8%
Q2 2021$77,001,000
+11.7%
790,567
+1.2%
0.38%
+1.6%
Q1 2021$68,964,000
-48.2%
781,459
-43.8%
0.37%
-43.6%
Q4 2020$133,045,000
-16.3%
1,390,517
-0.7%
0.66%
-32.7%
Q3 2020$158,941,000
+13.0%
1,400,361
-1.5%
0.98%
-11.0%
Q2 2020$140,670,000
+72.6%
1,422,057
+12.3%
1.10%
+12.7%
Q1 2020$81,515,000
+11.0%
1,266,746
+2.9%
0.98%
+28.2%
Q4 2019$73,414,000
+98.6%
1,231,566
+96.5%
0.76%
+79.7%
Q3 2019$36,958,000
-9.8%
626,611
-1.3%
0.42%
+2.7%
Q2 2019$40,975,000
+20.2%
635,079
+18.3%
0.41%
+13.5%
Q1 2019$34,078,000
+658.8%
536,654
+353.8%
0.36%
+468.8%
Q4 2018$4,491,000
+2481.0%
118,266
+2819.4%
0.06%
+3100.0%
Q3 2018$174,0004,0510.00%
Other shareholders
TANDEM DIABETES CARE INC shareholders Q2 2020
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 474,929$22,725,0003.92%
Soleus Capital Management, L.P. 415,200$19,867,0002.70%
First Light Asset Management, LLC 485,620$23,237,0002.35%
Eagle Health Investments LP 196,400$9,398,0002.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 218,049$10,434,0001.66%
EMINENCE CAPITAL, LP 1,590,787$76,119,0001.59%
Brown Capital Management 2,010,230$96,190,0001.35%
Chicago Capital, LLC 479,873$22,962,0001.33%
Intrinsic Edge Capital Management LLC 247,391$11,838,0001.29%
Bellevue Group AG 1,566,015$74,933,0001.08%
View complete list of TANDEM DIABETES CARE INC shareholders